Lactate profiles as a resuscitation assessment tool in a rat model of battlefield hemorrhage resuscitation.
Time profiles of arterial lactate concentrations have been proposed as markers for both the degree of physiological derangement during shock and effectiveness of clinical resuscitation, but have not been evaluated for use in short-term experimental protocols. We developed two quantitative mixed models of sequential arterial lactate concentrations to evaluate competing low-volume (<4 mL/kg) battlefield resuscitation therapies in a rat model of acute severe hemorrhagic shock: a simple linear additive model and a nonlinear mechanistic model that described lactate profiles in a continuous trajectory with a defined turning point. Data were obtained during a study evaluating a novel hemoglobin polymer (OxyVita) in a cocktail of hypertonic saline and Hextend as an alternative to standard Hextend. Fluids were either infused by titration to a mean systolic pressure of 60 mmHg or as a single bolus. Parameter estimates derived from both models were assessed for evidence of treatment efficacy and as indicators of short-term survival. A cocktail of hypertonic saline and Hextend was superior to standard Hextend in enhancing survival; however, lactate profiles did not differ between treatments. Regardless of resuscitation regimen, animals surviving to at least 60 min posthemorrhage can be discriminated from nonsurvivors by significantly lower peak lactates (a difference of at least 3 mM; P < 0.001), and all survivors exhibited a decline in lactate with resuscitation. Sequential measurements of lactate over relatively short time frames during resuscitation are of value in assessing both response to resuscitation and short-term mortality.
Department of Emergency Medicine, Virginia Commonwealth University Medical Center, Richmond, Virginia 23298-0401, USA. psreynolds@vcu.edu
Penny S
PS
Reynolds
R Wayne
RW
Barbee
Kevin R
KR
Ward
D000818:Animals; D004195:Disease Models, Animal; D006454:Hemoglobins / Q000627:therapeutic use; D006895:Hydroxyethyl Starch Derivatives / Q000627:therapeutic use; D019344:Lactic Acid / Q000097:blood*; D008297:Male; D051381:Rats; D020318:Rats, Long-Evans; D012151:Resuscitation / Q000379:methods*; D012462:Saline Solution, Hypertonic / Q000627:therapeutic use; D012771:Shock, Hemorrhagic / Q000628:therapy*
D006454:Hemoglobins; D006895:Hydroxyethyl Starch Derivatives; C529085:OxyVita; D012462:Saline Solution, Hypertonic; D019344:Lactic Acid